Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지

Markers of Collagen Change in Chronic Secondary Renal Disease Model in Rat

만성 속발성 신질환 모델동물에서 콜라젠 변화의 지표

  • 남정석 (서울대학교 수의과대학 공중보건학실) ;
  • 김기영 (원광대학교 의과대학 병리학교실) ;
  • 이영순 (서울대학교 수의과대학 공중보건학실)
  • Published : 1996.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

In order to develop a suitable secondary renal disease model and diagnostic markers of renal disease in the rat, the change of PIIIP (aminoterminal procollagen III peptide) in serum and hydroxyproline levels in the renal tissue that reflect the synthesis of extracellular matrix (ECM) during development of experimental renal diseases were observed. Two types of experimental primary diseases, diabetes mellitus administrated by streptozotocin (STZ, 75 mg/kg, i.p.) and liver cirrhosis produced by bile duct ligation/scission (BDL/s) operation, were induced. The hydroxyproline level increased according to the high PIIIP and NCl(carboxyterminal procollagen IV peptide) in Western blot analysis as early as 1 week in the STZ treated-rat kidney. Increased renal ECM was observed at 15 weeks in STZ and BDL/s model under the microscopic examination. High PAS positive reaction was found in capillary basement membrane in STZ treated-rats and mesangium in BDL/s operated rats at this time, showing the histological characteristics of diabetic nephropathy and cirrhotic glomerulonephritis in human, respectively. Such secondary renal failure were supported by additional tests including urinalysis and renal function test. The serum PIIIP detected by ELISA was a useful parameter to estimate synthesis rate of renal ECM during development of renal disease without extrarenal fibrosis i.e. liver cirrhosis in rats. This study is proposed that STZ treatment or BDL/s operation may be a suitable experimental animal model for the induction and development of chronic secondary renal diseases. Morover, it was found that hydroxyproline level in renal tissues was a good parameter of the change of renal ECM at the early stage of the diseases without apparent histological changes. Especially, serum PIIIP could be a choice as a diagnostic or prognostic marker during the development of renal diseases in rats.

Keywords

References

  1. Diabetes, In vivo studies v.28 Glomerular basement membrane metabolism in the diabetic rat Brownlee M.;Spiro R.G.
  2. Diabetes v.37 Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats Christine K.A.;Carl V.P.;Gregory J.R.
  3. Biochem Biophys Acta v.500 In vivo biosythesis in streptozotocin diabetes Cohen M.P.;Surma M.L.;Van Yu Wu
  4. Am. J. Pathol. v.52 Cirrhotic(hepatic) lobular glomerulonephritis:Correlation of ultrastructural and clinical features Fisher E.R.;Perez stable E.
  5. J. Lab. Clin. Med. v.125 In vivo effects of hyperglycemia on the outcome of acute mesangial injury in rats Futoshi Y.;Ken ichi I.;Seiichi M.
  6. Am. J. Pathol. v.11 no.3 Cirrhotic glomerulonephritis:incidence, morphology, clinical features;pathogenesis Glenn C.;Newell M.D.
  7. Collagen metabolism in liver disease;Liver in Metabolic disease. Folk Symp. 35. Hahn E.G.;Schuppan D.;Bianchi L.(ed.);Gerocker W.(ed.);Landmann L.(ed.)(et al.)
  8. Diabetologia v.26 Glomerular basement membrane synthesis and serum concentration of type Ⅳ collagen in streptozotocin-diabetic rats Hasslacher C.H.;Reichenbacher R.;Gechter F.;Timple R.
  9. Anal. Biochem. v.112 A simple method to determine nanogram levels of 4-hydroxyproline in biological tissures Jamall I.S.;Finelli V.N.;Que H.S.
  10. Kidney Int. v.30 Effect of age and diabetes on type Ⅳ collagen and laminin in human kidney cortex Karttunen T.;Risteli J.;Autio Harmainen H(et al.)
  11. Human Pathol v.17 no.11 Glomerular lesions associated with liver cirrhosis; An immunohistochemical and clinicopathologic analysis Kawaguchi K.;Koike M.
  12. Europ. J. Clin. Invest. v.22 Raised concentrations of the carboxyterminal propeptide of type Ⅳ(basement membrane procollagen(NC1) in serum and urine of patients with glomerulonephritis Keller F.;Schupan D.
  13. Nephron v.50 Increased procollagen Ⅲ production in patients with kidney disease Keller F.;Rehbein C.;Schwarz A.;Fleck M.;Hayasaka A.;Schuppan D(et al.)
  14. Clinicopathological study on the relationship between appearance of type Ⅰ or Ⅲ collagen in IgA nephropathy Nippon-Jinzo-Gakkai-Shi v.34 no.6 Ozu H.
  15. J. pathol. v.174 no.2 In situ localization of type Ⅲ and type Ⅳ collagen-expressing cells in human diabetic nephropathy Razzaque M.S.;Koji T.;Taguchi T.;Harada T.;Nakane P.K.
  16. Gastroenterology v.76 Collagen types in normal and cirrhotic liver Rojkind H.;Giambrone M.A.;Biempica L.
  17. Semiars in liver disease v.10 no.1 Connective tissue polypeptides matrix in normal and fibrotic liver;collagens and glycoproteins Schuppan D.
  18. J. Hepatol v.3 Serum concentration of the aminoterminal procollagen type Ⅲ peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis Schuppan D.;Dumont J.M.;Kim K.Y.(et al.)
  19. Am. J. Pathol. v.125 Mesangial cell hillocks. Nodullar foci of exaggerated growth of cells and matrix in prolonged culture Sterzel R.B.;Lovett D.H.;Foellmer H.G.(et al.)
  20. Scan J. Clin. Lab. Invest. v.49 A new enzyme-linked immunosorbant assay for urine and serum concentrations of the carboxyterminal domain(NC1) of collagen Ⅳ;application in typeⅠ(insulin-dependent) diabetes Torffuit O.;Agardh B.;Cederholm B.;Wieslander J.
  21. Nephron v.45 Evidence for development changes of type Ⅳ collagen in glomerular basement membrane Wingen A.M.;Dohner H.;Scharer K.(et al.)
  22. Nephron v.70 Differential distribution of type Ⅳ collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus Yagame M.;Kim Y.G.;Sakai H.;Groppoli T.
  23. 대한신장학회지 v.9 no.4 사구체 경화증에서의 콜라젠 유전자 표현양식 임천규